Amy Schulman
Executive Vice President and General Counsel; President and General Manager, Nutrition

Amy W. Schulman is recognized as an innovative, results-focused leader in the legal and health care professions and a champion for diversity and womenýs professional advancement. As General Counsel, she heads a division of professionals who handle some of the most complex, challenging legal matters within a highly regulated industry. As head of Nutrition, she is responsible for driving an over $2 billion, global business.

At Pfizer, Ms. Schulman devised a groundbreaking approach to engaging outside counsel that transforms the traditional billable-hour model and produces better results for the company and its firms. In a December 2009 cover story, The American Lawyer wrote: "Amy Schulman knows how the game is played and has set out to change all the rules." Ms. Schulman and the Pfizer Legal Alliance also have been featured in numerous other publications, including The Wall Street Journal, The Financial Times, The New York Times and The American Lawyer.

Ms. Schulman joined Pfizer as General Counsel in June 2008, when the company was exploring the purchase of Wyeth Pharmaceuticals. She played a key role in the negotiations leading up to what became the largest pharmaceutical acquisition in history. Prior to the acquisition, she was instrumental in negotiating settlements of high-profile personal injury, consumer fraud and state lawsuits involving Pfizerýs non-steroidal anti-inflammatory pain medications.

Before joining Pfizer, Ms. Schulman was a senior partner at DLA Piper, among the world's largest law firms, from 1997-2008. She built and led the firm's mass tort and class-action practice, with clients including GE Healthcare, Cisco, Wyeth, Philip Morris, Kraft Foods and Pfizer. Ms. Schulman began her legal career as a litigation associate with Cleary Gottlieb.

Ms. Schulman is Executive Sponsor of Pfizer's Global Women's Council, where she helps shape efforts to increase diversity and expand opportunities for both women and men across the company. In part due to the parity programs Ms. Schulman helps to lead, Pfizer has seen a significant increase of women in senior level jobs from 2009 to 2011.

Her commitment to clients, professional development, legal advocacy skills and reform has earned her accolades from many leading publications and organizations. To name a few, The National Law Journal included her on its inaugural list of the 20 Most Influential General Counsel in 2009, and Forbes magazine included her on its list of "The World's Most Powerful Women" the same year. She was one of 10 "leading lights" featured in The Financial Times' 2011 U.S. Innovative Lawyers report. She is a visiting professor at Yale Law School, and a guest lecturer at Harvard Business School and Tsinghua University in Beijing.

A Phi Beta Kappa graduate of Wesleyan University, Ms. Schulman earned her J.D. from Yale Law School in 1989. She serves on the Board of Directors of the International Association of Infant Food Manufacturers, Wesleyan University and the Brooklyn Academy of Music.